IT workers brace for outsourcing, layoffs at health insurer – Computerworld

Employees anticipate that the IT work will be moved offshore, and that they will be training their replacements. They are concerned that the outsourcing will follow the playbook used at other companies, where employees train H-1B visa holders brought in by contractors, and that the training must be completed as a condition of severance.

Source: IT workers brace for outsourcing, layoffs at health insurer | Computerworld

Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes Clinical Perspective – Circulation

CONCLUSIONS: Patients with FH and ACS have a >2-fold adjusted risk of coronary event recurrence within the first year after discharge than patients without FH despite the widespread use of high-intensity statins. # Clinical Perspective {#article-title-36}

Source: Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesClinical Perspective | Circulation

An Open Letter To Tiny House Hunters – terribleminds: chuck wendig

Source: An Open Letter To Tiny House Hunters « terribleminds: chuck wendig

“Which one did they pick?”

“You fell asleep again, didn’t you?”

This post is for all of the spouses out there subjected to the nightly ritual of watching some version of a house hunting show on HGTV.

Read. Laugh. Repeat.  (don’t skip the reader comments cuz they are priceless).

Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries — United States, 2014 – MMWR

Source: Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries — United States, 2014 | MMWR

Conclusions and Implications for Public Health Practice:

More than one in four Medicare Part D beneficiaries using anti-hypertensives were non-adherent to their regimen, and certain racial/ethnic groups, states, and geographic areas were at increased risk for non-adherence.

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis – The BMJ

Objective To quantify the association between atrial fibrillation and cardiovascular disease, renal disease, and death. Design Systematic review and meta-analysis. Data sources Medline and Embase. Eligibility criteria Cohort studies examining the association between atrial fibrillation and cardiovascular disease, renal disease, and death. Two reviewers independently extracted study characteristics and the relative risk of outcomes associated with atrial fibrillation: specifically, all cause mortality, cardiovascular mortality, major cardiovascular events, any stroke, ischaemic stroke, haemorrhagic stroke, ischaemic heart disease, sudden cardiac death, congestive heart failure, chronic kidney disease, and peripheral arterial disease. Estimates were pooled with inverse variance weighted random effects meta-analysis. Results 104 eligible cohort studies involving 9 686 513 participants (587 867 with atrial fibrillation) were identified. Atrial fibrillation was associated with an increased risk of all cause mortality (relative risk 1.46, 95% confidence interval 1.39 to 1.54), cardiovascular mortality (2.03, 1.79 to 2.30), major cardiovascular events (1.96, 1.53 to 2.51), stroke (2.42, 2.17 to 2.71), ischaemic stroke (2.33, 1.84 to 2.94), ischaemic heart disease (1.61, 1.38 to 1.87), sudden cardiac death (1.88, 1.36 to 2.60), heart failure (4.99, 3.04 to 8.22), chronic kidney disease (1.64, 1.41 to 1.91), and peripheral arterial disease (1.31, 1.19 to 1.45) but not haemorrhagic stroke (2.00, 0.67 to 5.96). Among the outcomes examined, the highest absolute risk increase was for heart failure. Associations between atrial fibrillation and included outcomes were broadly consistent across subgroups and in sensitivity analyses. Conclusions Atrial fibrillation is associated with an increased risk of death and an increased risk of cardiovascular and renal disease. Interventions aimed at reducing outcomes beyond stroke are warranted in patients with atrial fibrillation.

Source: Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis | The BMJ